Last reviewed · How we verify
Immune Support (CURCUMIN)
At a glance
| Generic name | CURCUMIN |
|---|---|
| Sponsor | ProBLEN |
| Drug class | Vitamin C [EPC] |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- low or imbalance immune system
Common side effects
Key clinical trials
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy (PHASE3)
- Effectiveness of Curcuminoids in Controlling Postoperative Pain Following Total Laparoscopic Hysterectomy (PHASE4)
- The Assessment of Curcuma Longa Potentials for Soft and Hard Tissue Healing in Fresh (PHASE1)
- Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms (PHASE2)
- Clinical Efficacy of NST With Adjunctive Local Delivery of Ozonated Olive Versus Curcumin Gel in Stage II Grade B Periodontitis. (NA)
- Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome. (NA)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |